Clinical Comparison of Two Daily Disposable Soft Contact Lenses

Not Applicable

Completed

Interventions: Device: verofilcon A contact lenses
Device: somofilcon A contact lenses

Brief Summary: The purpose of this study is to evaluate the overall performance of investigational contact lenses (DD T2) when compared to clariti® 1 day contact lenses.

Recruitment & Eligibility

Inclusion Criteria

Understand and sign an Informed Consent Form;
Successful wear of daily disposable spherical soft contact lenses in both eyes for a minimum of 5 days per week and 8 hours per day during the past 3 months;
Best-corrected visual acuity (BCVA) 20/25 or better in each eye;
Willing to stop wearing habitual contact lenses for the duration of study participation;
Other protocol-specified inclusion criteria may apply.

Exclusion Criteria

Anterior segment infection, inflammation, or abnormality or disease that contraindicates contact lens wear, as determined by the Investigator;
Use of systemic or ocular medications for which contact lens wear could be contraindicated, as determined by the Investigator;
Refractive, ocular, or intraocular surgery, as specified in the protocol;
Eye condition or injury, as specified in the protocol;
Current or history of intolerance, hypersensitivity, or allergy to any component of the study products;
Wearing habitual contact lenses in an extended wear modality (routinely sleeping in lenses for at least 1 night per week) over the last 3 months prior to enrollment;
Use of topical ocular medications and artificial tear or rewetting drops requiring instillation during contact lens wear;
Currently wearing clariti® 1 day contact lenses;
Habitually wearing monovision or multifocal lenses during the last 3 months;
Other protocol-specified exclusion criteria may apply.

Arm && Interventions

Group	Intervention	Description
DD T2, then Clariti 1 Day	verofilcon A contact lenses	Verofilcon A contact lenses worn first, with somofilcon A contact lenses worn second. Each product worn bilaterally (in both eyes) for 1 week in a daily disposable modality.
DD T2, then Clariti 1 Day	somofilcon A contact lenses	Verofilcon A contact lenses worn first, with somofilcon A contact lenses worn second. Each product worn bilaterally (in both eyes) for 1 week in a daily disposable modality.
Clariti 1 Day, then DD T2	somofilcon A contact lenses	Somofilcon A contact lenses worn first, with verofilcon A contact lenses worn second. Each product worn bilaterally for 1 week in a daily disposable modality.
Clariti 1 Day, then DD T2	verofilcon A contact lenses	Somofilcon A contact lenses worn first, with verofilcon A contact lenses worn second. Each product worn bilaterally for 1 week in a daily disposable modality.

Primary Outcome Measures

Name	Time	Method
Overall Quality of Vision	Day 8, each product	Overall quality of vision was measured as a subjective rating, collected binocularly on a scale of 1 (Poor) to 10 (Excellent). No inferences were made; therefore, no hypotheses were formulated.

Secondary Outcome Measures